Jonathan S. Goldberg

1.2k total citations · 1 hit paper
11 papers, 960 citations indexed

About

Jonathan S. Goldberg is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonathan S. Goldberg has authored 11 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonathan S. Goldberg's work include Peptidase Inhibition and Analysis (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Ubiquitin and proteasome pathways (2 papers). Jonathan S. Goldberg is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Ubiquitin and proteasome pathways (2 papers). Jonathan S. Goldberg collaborates with scholars based in United States, France and Australia. Jonathan S. Goldberg's co-authors include Thomas J. Lynch, Lecia V. Sequist, Jeffrey Settleman, Pasi A. Jänne, Alona Muzikansky, Daniel A. Haber, Georgiana Kuhlmann, Renato Martins, A. John Iafrate and Jeffrey A. Engelman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Jonathan S. Goldberg

10 papers receiving 939 citations

Hit Papers

First-Line Gefitinib in P... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations
    2008 661 citations Lecia V. Sequist, Renato Martins et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan S. Goldberg United States 9 597 527 359 199 107 11 960
Bu-Er Wang United States 10 440 0.7× 324 0.6× 519 1.4× 191 1.0× 85 0.8× 14 946
Chara Papadaki Greece 20 257 0.4× 493 0.9× 559 1.6× 435 2.2× 57 0.5× 53 1.0k
Anne Offermann Germany 17 322 0.5× 308 0.6× 366 1.0× 166 0.8× 58 0.5× 55 820
Amanda Youmans United States 7 558 0.9× 458 0.9× 518 1.4× 328 1.6× 86 0.8× 11 1.3k
Lorena Bottarelli Italy 18 367 0.6× 661 1.3× 454 1.3× 190 1.0× 111 1.0× 51 1.1k
Roxanne Toivanen Australia 15 937 1.6× 558 1.1× 597 1.7× 374 1.9× 121 1.1× 21 1.5k
Clémentine Le Magnen Switzerland 15 438 0.7× 351 0.7× 455 1.3× 264 1.3× 86 0.8× 22 939
Ruth F. Dumpit United States 15 504 0.8× 217 0.4× 481 1.3× 274 1.4× 47 0.4× 20 913
Oscar B. Goodman United States 16 528 0.9× 385 0.7× 405 1.1× 335 1.7× 49 0.5× 33 1.0k
Zhiyong Ma China 16 525 0.9× 642 1.2× 261 0.7× 137 0.7× 64 0.6× 43 952

Countries citing papers authored by Jonathan S. Goldberg

Since Specialization
Citations

This map shows the geographic impact of Jonathan S. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Goldberg more than expected).

Fields of papers citing papers by Jonathan S. Goldberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Goldberg. The network helps show where Jonathan S. Goldberg may publish in the future.

Co-authorship network of co-authors of Jonathan S. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Goldberg. A scholar is included among the top collaborators of Jonathan S. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Goldberg. Jonathan S. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
3.
Gordon, Chad R., Mohammed S. Alghoul, Jonathan S. Goldberg, Mutaz B. Habal, & Francis Papay. (2011). Diced Cartilage Grafts Wrapped in AlloDerm for Dorsal Nasal Augmentation. Journal of Craniofacial Surgery. 22(4). 1196–1199. 67 indexed citations
4.
5.
Sequist, Lecia V., Renato Martins, David R. Spigel, et al.. (2008). First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations. Journal of Clinical Oncology. 26(15). 2442–2449. 661 indexed citations breakdown →
6.
Goldberg, Jonathan S., et al.. (2005). Retinoic Acid and the Histone Deacetylase Inhibitor Trichostatin A Inhibit the Proliferation of Human Renal Cell Carcinoma in a Xenograft Tumor Model. Clinical Cancer Research. 11(9). 3558–3566. 65 indexed citations
7.
Kelly, John D., Juncheng Dai, Pascal Eschwège, et al.. (2004). Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas. British Journal of Cancer. 91(1). 164–170. 20 indexed citations
8.
Goldberg, Jonathan S., Matthew I. Milowsky, Lorraine J. Gudas, et al.. (2002). Phase I trial of interferon α2b and liposome‐encapsulated all‐trans retinoic acid in the treatment of patients with advanced renal cell carcinoma. Cancer. 95(6). 1220–1227. 19 indexed citations
9.
Shen, R, Makoto Sumitomo, Jonathan S. Goldberg, et al.. (2001). Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.. PubMed. 7(5). 1370–7. 49 indexed citations
10.
Sumitomo, Makoto, Ruoqian Shen, Jonathan S. Goldberg, et al.. (2000). Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.. PubMed. 60(23). 6590–6. 35 indexed citations
11.
Krakowski, I., J. Meynadier, P. Poulain, et al.. (1996). Recommandations pour une bonne pratique dans la prise en charge de la douleur du cancer chez l'adulte et l'enfant. 82(83). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bu-Er Wang Breakdown of academic impact, for papers by Chara Papadaki Breakdown of academic impact, for papers by Anne Offermann Breakdown of academic impact, for papers by Amanda Youmans Breakdown of academic impact, for papers by Lorena Bottarelli Breakdown of academic impact, for papers by Roxanne Toivanen Breakdown of academic impact, for papers by Clémentine Le Magnen Breakdown of academic impact, for papers by Ruth F. Dumpit Breakdown of academic impact, for papers by Oscar B. Goodman Breakdown of academic impact, for papers by Zhiyong Ma
Rankless by CCL
2026